D-0518-2020 Class II Terminated

Recalled by Teva Pharmaceuticals USA, Inc. — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
November 27, 2019
Initiation Date
November 4, 2019
Termination Date
November 17, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,623 bottles

Product Description

Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actavis Laboratories FL. Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-2579-20

Reason for Recall

Presence of foreign substance: Brown/black particles found during stability testing.

Distribution Pattern

Product was distributed to wholesalers/distributors throughout the United States.

Code Information

Lot #: CBFCN, CBHFG, Exp 05/2020